176 related articles for article (PubMed ID: 33651885)
1. Retinoids in hematology: a timely revival?
Geoffroy MC; Esnault C; de Thé H
Blood; 2021 May; 137(18):2429-2437. PubMed ID: 33651885
[TBL] [Abstract][Full Text] [Related]
2. Novel treatment of acute promyelocytic leukemia: As₂O₃, retinoic acid and retinoid pharmacology.
Zhu G
Curr Pharm Biotechnol; 2013; 14(9):849-58. PubMed ID: 24433507
[TBL] [Abstract][Full Text] [Related]
3. Retinoid receptor signaling and autophagy in acute promyelocytic leukemia.
Orfali N; McKenna SL; Cahill MR; Gudas LJ; Mongan NP
Exp Cell Res; 2014 May; 324(1):1-12. PubMed ID: 24694321
[TBL] [Abstract][Full Text] [Related]
4. Recurrent
Osumi T; Tsujimoto SI; Tamura M; Uchiyama M; Nakabayashi K; Okamura K; Yoshida M; Tomizawa D; Watanabe A; Takahashi H; Hori T; Yamamoto S; Hamamoto K; Migita M; Ogata-Kawata H; Uchiyama T; Kizawa H; Ueno-Yokohata H; Shirai R; Seki M; Ohki K; Takita J; Inukai T; Ogawa S; Kitamura T; Matsumoto K; Hata K; Kiyokawa N; Goyama S; Kato M
Cancer Res; 2018 Aug; 78(16):4452-4458. PubMed ID: 29921692
[TBL] [Abstract][Full Text] [Related]
5. Hematopoiesis and retinoids: development and disease.
Oren T; Sher JA; Evans T
Leuk Lymphoma; 2003 Nov; 44(11):1881-91. PubMed ID: 14738139
[TBL] [Abstract][Full Text] [Related]
6. 9-cis-retinoic acid: effects on normal and leukemic hematopoiesis in vitro.
Sakashita A; Kizaki M; Pakkala S; Schiller G; Tsuruoka N; Tomosaki R; Cameron JF; Dawson MI; Koeffler HP
Blood; 1993 Feb; 81(4):1009-16. PubMed ID: 8427982
[TBL] [Abstract][Full Text] [Related]
7. Uncoupling RARA transcriptional activation and degradation clarifies the bases for APL response to therapies.
Ablain J; Leiva M; Peres L; Fonsart J; Anthony E; de Thé H
J Exp Med; 2013 Apr; 210(4):647-53. PubMed ID: 23509325
[TBL] [Abstract][Full Text] [Related]
8. PML-RARA-RXR oligomers mediate retinoid and rexinoid/cAMP cross-talk in acute promyelocytic leukemia cell differentiation.
Kamashev D; Vitoux D; De Thé H
J Exp Med; 2004 Apr; 199(8):1163-74. PubMed ID: 15096541
[TBL] [Abstract][Full Text] [Related]
9. Retinoids as regulators of gene transcription.
Mehta K
J Biol Regul Homeost Agents; 2003; 17(1):1-12. PubMed ID: 12757018
[TBL] [Abstract][Full Text] [Related]
10. RARA and RARG gene downregulation associated with EZH2 mutation in acute promyelocytic-like morphology leukemia.
Coccaro N; Zagaria A; Orsini P; Anelli L; Tota G; Casieri P; Impera L; Minervini A; Minervini CF; Cumbo C; Parciante E; Mestice A; Delia M; Brunetti C; Specchia G; Albano F
Hum Pathol; 2018 Oct; 80():82-86. PubMed ID: 29530751
[TBL] [Abstract][Full Text] [Related]
11. The genetics and clinical characteristics of children morphologically diagnosed as acute promyelocytic leukemia.
Zhao J; Liang JW; Xue HL; Shen SH; Chen J; Tang YJ; Yu LS; Liang HH; Gu LJ; Tang JY; Li BS
Leukemia; 2019 Jun; 33(6):1387-1399. PubMed ID: 30575821
[TBL] [Abstract][Full Text] [Related]
12. A novel NPM1-RARG-NPM1 chimeric fusion in acute myeloid leukaemia resembling acute promyelocytic leukaemia but resistant to all-trans retinoic acid and arsenic trioxide.
Chen X; Wang F; Zhang Y; Teng W; Cao P; Ma X; Liu M; Tian Y; Wang T; Nie D; Zhang J; Liu H; Wang W
Br J Cancer; 2019 May; 120(11):1023-1025. PubMed ID: 30996344
[TBL] [Abstract][Full Text] [Related]
13. Retinoids in the treatment of acute promyelocytic leukemia. Review of the literature.
Graf N; Riesinger P; Reinhard H
Klin Padiatr; 1995; 207(2):43-7. PubMed ID: 7752598
[TBL] [Abstract][Full Text] [Related]
14. [Mechanism of action of retinoids in a new therapeutic approach to acute promyelocytic leukemia].
Cornic M; Guidez F; Delva L; Agadir A; Degos L; Chomienne C
Bull Cancer; 1992; 79(7):697-704. PubMed ID: 1334741
[TBL] [Abstract][Full Text] [Related]
15. CCAAT/enhancer binding protein epsilon is a potential retinoid target gene in acute promyelocytic leukemia treatment.
Park DJ; Chumakov AM; Vuong PT; Chih DY; Gombart AF; Miller WH; Koeffler HP
J Clin Invest; 1999 May; 103(10):1399-408. PubMed ID: 10330422
[TBL] [Abstract][Full Text] [Related]
16. RARalpha-PLZF overcomes PLZF-mediated repression of CRABPI, contributing to retinoid resistance in t(11;17) acute promyelocytic leukemia.
Guidez F; Parks S; Wong H; Jovanovic JV; Mays A; Gilkes AF; Mills KI; Guillemin MC; Hobbs RM; Pandolfi PP; de Thé H; Solomon E; Grimwade D
Proc Natl Acad Sci U S A; 2007 Nov; 104(47):18694-9. PubMed ID: 18000064
[TBL] [Abstract][Full Text] [Related]
17. Leukemia: beneficial actions of retinoids and rexinoids.
Altucci L; Wilhelm E; Gronemeyer H
Int J Biochem Cell Biol; 2004 Feb; 36(2):178-82. PubMed ID: 14643883
[TBL] [Abstract][Full Text] [Related]
18. High-dose ascorbate and arsenic trioxide selectively kill acute myeloid leukemia and acute promyelocytic leukemia blasts in vitro.
Noguera NI; Pelosi E; Angelini DF; Piredda ML; Guerrera G; Piras E; Battistini L; Massai L; Berardi A; Catalano G; Cicconi L; Castelli G; D'Angiò A; Pasquini L; Graziani G; Fioritoni G; Voso MT; Mastrangelo D; Testa U; Lo-Coco F
Oncotarget; 2017 May; 8(20):32550-32565. PubMed ID: 28427227
[TBL] [Abstract][Full Text] [Related]
19. Induction of retinoid resistance by all-trans retinoic acid in acute promyelocytic leukemia after remission.
Cornic M; Chomienne C
Leuk Lymphoma; 1995 Jul; 18(3-4):249-57. PubMed ID: 8535190
[TBL] [Abstract][Full Text] [Related]
20.
Nguyen CH; Grandits AM; Purton LE; Sill H; Wieser R
Cell Cycle; 2020 Oct; 19(20):2573-2588. PubMed ID: 32900260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
